Scorpius Holdings Receives NYSE American Notice of Delisting and Reports Plans to Appeal
San Antonio, TX, April 21, 2025 (GLOBE NEWSWIRE) — Scorpius Holdings, Inc (NYSE American: SCPX) (“Scorpius” or “the Company”), an…
Pharmaceuticals, Biotechnology and Life Sciences
San Antonio, TX, April 21, 2025 (GLOBE NEWSWIRE) — Scorpius Holdings, Inc (NYSE American: SCPX) (“Scorpius” or “the Company”), an…
AUSTIN, Texas, April 21, 2025 (GLOBE NEWSWIRE) — Cassava Sciences, Inc. (NASDAQ: SAVA, “Cassava”, the “Company”), a clinical-stage biotechnology company…
TORONTO, April 21, 2025 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a…
Company to conduct 1×1 meetings on April 24, 2025GAITHERSBURG, Md., April 21, 2025 (GLOBE NEWSWIRE) — Shuttle Pharmaceuticals Holdings, Inc.…
IRVINE, Calif., April 21, 2025 (GLOBE NEWSWIRE) — AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE: AEON), a clinical-stage biopharmaceutical…
Dr. Tyler Korman, co-founder and VP of Research at eXoZymes, is excited about the ‘exozymes’ cover story in GEN Biotechnology,…
Mr. Henry Gosebruch appointed by the Galapagos Board of Directors as founding CEO of newly created SpinCo Dr. Paul Stoffels,…
Study published in the Journal of Clinical PsychopharmacologySALT LAKE CITY, April 21, 2025 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ:…
Hanover, MA , April 20, 2025 (GLOBE NEWSWIRE) — Boston Hemp Inc., a leader in compliant hemp-derived cannabis, today announced…
NEW YORK, April 16, 2025 (GLOBE NEWSWIRE) — Mesoblast (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases,…